• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布里病的神经学表现

Neurological manifestations of Fabry disease

作者信息

Schiffmann Raphael, Moore David F

机构信息

Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, Building 10, Room 3D03, National Institutes of Health, Bethesda, Maryland, 20892-1260, USA

Section of Neurology, Department of Internal Medicine, University of Manitoba, Winnipeg, Canada

PMID:21290698
Abstract

The neurological manifestations of Fabry disease include both peripheral nervous system and CNS involvement, with globotriaosylceramide accumulation found in Schwann cells and dorsal root ganglia together with deposits in CNS neurones. The main involvement of the CNS is attributable to cerebrovasculopathy, with an increased incidence of stroke. The abnormal neuronal accumulation of glycosphingolipid appears to have little clinical effect on the natural history of Fabry disease, with the possible exception of some reported mild cognitive abnormalities. The pathogenesis of Fabry vasculopathy remains poorly understood, but probably relates, in part, to abnormal functional control of the vessels, secondary to endothelial dysfunction as a consequence of α-galactosidase A deficiency. Obstructive vasculopathy, either primarily due to accumulation of glycolipid or secondary to consequent inflammation and confounding vascular risk factors, may develop in response to abnormal endothelial and vessel wall function, similar in some respects to that observed with accumulation of cholesterol-laden lipids during atherosclerosis. Involvement of the peripheral nervous system affects mainly small Aδ and C fibres, and is probably causally related to the altered autonomic function and neuropathic pain found in Fabry disease. Other related neurological problems include hypohidrosis and other abnormalities associated with nervous system dysfunction.

摘要

法布里病的神经学表现包括外周神经系统和中枢神经系统受累,在施万细胞和背根神经节中发现有球三糖基神经酰胺蓄积,同时中枢神经系统神经元中也有沉积物。中枢神经系统的主要受累归因于脑血管病变,中风发生率增加。糖鞘脂在神经元中的异常蓄积似乎对法布里病的自然病程几乎没有临床影响,可能除了一些报道的轻度认知异常外。法布里血管病变的发病机制仍知之甚少,但可能部分与血管功能的异常控制有关,这继发于α-半乳糖苷酶A缺乏导致的内皮功能障碍。阻塞性血管病变,要么主要由于糖脂蓄积,要么继发于随之而来的炎症和混杂的血管危险因素,可能是对内皮和血管壁功能异常的反应而发生,在某些方面类似于动脉粥样硬化期间富含胆固醇的脂质蓄积时观察到的情况。外周神经系统受累主要影响小的Aδ和C纤维,可能与法布里病中发现的自主神经功能改变和神经性疼痛有因果关系。其他相关的神经问题包括少汗症和与神经系统功能障碍相关的其他异常。

相似文献

1
Neurological manifestations of Fabry disease法布里病的神经学表现
2
Anderson-Fabry disease: a multiorgan disease.安德森-法布里病:一种多系统疾病。
Curr Pharm Des. 2013;19(33):5974-96. doi: 10.2174/13816128113199990352.
3
Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy.神经病与法布里病:发病机制及酶替代疗法
Acta Neurol Belg. 2006 Jun;106(2):61-5.
4
Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson-Fabry Disease.安德森-法布里病中枢及周围神经系统并发症的分子发病机制。
Int J Mol Sci. 2023 Dec 20;25(1):61. doi: 10.3390/ijms25010061.
5
Neurological complications of Anderson-Fabry disease.安德森-法布里病的神经系统并发症。
Curr Pharm Des. 2013;19(33):6014-30. doi: 10.2174/13816128113199990387.
6
The cerebral vasculopathy of Fabry disease.法布里病的脑血管病变。
J Neurol Sci. 2007 Jun 15;257(1-2):258-63. doi: 10.1016/j.jns.2007.01.053. Epub 2007 Mar 23.
7
Generation of an model for peripheral neuropathy in Fabry disease using CRISPR-Cas9 in the nociceptive dorsal root ganglion cell line 50B11.利用CRISPR-Cas9在伤害性背根神经节细胞系50B11中构建法布里病周围神经病变模型。
Mol Genet Metab Rep. 2022 Apr 27;31:100871. doi: 10.1016/j.ymgmr.2022.100871. eCollection 2022 Jun.
8
Neurological complications in Fabry disease.法布里病的神经系统并发症。
Rev Med Interne. 2010 Dec;31 Suppl 2:S243-50. doi: 10.1016/S0248-8663(10)70021-7.
9
Pathogenesis and Molecular Mechanisms of Anderson-Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies.安德森-法布里病的发病机制和分子机制及可能的新分子靶向治疗策略。
Int J Mol Sci. 2021 Sep 18;22(18):10088. doi: 10.3390/ijms221810088.
10
Cardiac manifestations of Fabry disease in G3Stg/GlaKO and GlaKO mouse models-Translation to Fabry disease patients.Fabry 病 G3Stg/GlaKO 和 GlaKO 小鼠模型的心脏表现——向 Fabry 病患者的转化。
PLoS One. 2024 May 31;19(5):e0304415. doi: 10.1371/journal.pone.0304415. eCollection 2024.